# Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer

> **NCT00821990** · PHASE3 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** Chemotherapy
- **OTHER:** Best supportive care

## Key facts

- **NCT ID:** NCT00821990
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-09
- **Final completion:** 2011-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2012-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00821990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00821990, "Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00821990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*